10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001213900-21-017556`
Period End Date	20201231
Filing Date	20210324
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	rlmd-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 52 Cash Flow Statement 127 Stockholders Equity 29

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$80.16M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$114.60M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$176.98K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$70.10K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$79.46K	USD	Point-in-time
Lease payments receivable short term	`LeaseIncentiveReceivableCurrent`	$73.09K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$520.75K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.46M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$903.19K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$423.86K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.74M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$118.07M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.46M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$116.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.98M	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$1.26K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$5.01K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$7.21K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$86.38K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$165.83K	USD	Point-in-time
Lease payments receivable long term	`LeaseIncentiveReceivableNoncurrent`	$203.14K	USD	Point-in-time
Total assets	`Assets`	$10.22M	USD	Point-in-time
Total assets	`Assets`	$117.14M	USD	Point-in-time
Total assets	`Assets`	$118.19M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$924.36K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$522.66K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$824.94K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.32M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$364.20K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$110.25K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.46M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.61M	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 16,332,939, 14,457,013 and 9,744,643 shares issued and outstanding, respectively	`CommonStockValue`	$16.33K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 16,332,939, 14,457,013 and 9,744,643 shares issued and outstanding, respectively	`CommonStockValue`	$9.74K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 16,332,939, 14,457,013 and 9,744,643 shares issued and outstanding, respectively	`CommonStockValue`	$14.46K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$284.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$235.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$119.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-119.86M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-179.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-111.66M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$105.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$115.68M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.61M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$10.22M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$118.19M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$117.14M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$7.86M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$35.97M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.51M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$24.87M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.70M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.25M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.76M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.73M	USD	Annual
Total operating expenses	`OperatingExpenses`	$15.11M	USD	Annual
Total operating expenses	`OperatingExpenses`	$60.84M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.27M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-12.73M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.27M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-15.11M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-60.84M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-54.63K	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-761.04K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$104.11K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNet`	$75.06K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$1.40M	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	2 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-156.21K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	$139.27K	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-3.77M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$75.06K	USD	2 Qtrs
Total other income (expenses), net	`NonoperatingIncomeExpense`	$1.38M	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-4.59M	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$104.11K	USD	Annual
Net loss	`NetIncomeLoss`	$-59.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.20M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.01M	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.62	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.77	USD	2 Qtrs
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-3.81	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-2.74	USD	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.24M	shares	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.59M	shares	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.58M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.31M	shares	Annual

Cash Flow Statement 127 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-17.32M	USD	Annual
Net loss	`ProfitLoss`	$-8.20M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-59.46M	USD	Annual
Net loss	`ProfitLoss`	$-15.01M	USD	Annual
Depreciation expense	`Depreciation`	$4.87K	USD	Annual
Depreciation expense	`Depreciation`	$2.20K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$3.75K	USD	Annual
Depreciation expense	`Depreciation`	$4.36K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.21M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$20.78M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$3.17M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.37M	USD	2 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	2 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-156.21K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	$139.27K	USD	Annual
Unrealized gain on short-term investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$661.17K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$54.63K	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	Annual
Fair value of shares relinquished	`FairValueOfSharesRelinquished`	-	USD	Annual
Fair value of shares relinquished	`FairValueOfSharesRelinquished`	$-394.41K	USD	Annual
Fair value of shares relinquished	`FairValueOfSharesRelinquished`	$-394.41K	USD	Annual
Fair value of shares relinquished	`FairValueOfSharesRelinquished`	-	USD	2 Qtrs
Loss on promissory note extinguishment	`LossOnPromissoryNoteExtinguishment`	$-3.77M	USD	Annual
Loss on promissory note extinguishment	`LossOnPromissoryNoteExtinguishment`	-	USD	Annual
Loss on promissory note extinguishment	`LossOnPromissoryNoteExtinguishment`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-270.17K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$479.33K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-96.88K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-471.91K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-176.98K	USD	2 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$169.36K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-73.09K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-67.23K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-34.32K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-64.49K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$163.77K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$158.92K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-401.70K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.82M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.43M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-492.92K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-565.61K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.41M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.09M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.50M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-27.81M	USD	Annual
Purchase of investments	`PaymentsToAcquireProductiveAssets`	$84.85M	USD	Annual
Purchase of investments	`PaymentsToAcquireProductiveAssets`	$182.05M	USD	Annual
Purchase of investments	`PaymentsToAcquireProductiveAssets`	$84.85M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireProductiveAssets`	-	USD	Annual
Sale of investments	`GainLossOnSaleOfInvestments`	-	USD	Annual
Sale of investments	`GainLossOnSaleOfInvestments`	$-4.68M	USD	Annual
Sale of investments	`GainLossOnSaleOfInvestments`	$-4.68M	USD	2 Qtrs
Sale of investments	`GainLossOnSaleOfInvestments`	$-147.60M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-80.16M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-80.16M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-34.45M	USD	Annual
Proceeds from issuance of common stock, net of fees	`ProceedsFromSaleOfEquityUnitsNetOfFees`	$19.79M	USD	Annual
Proceeds from issuance of common stock, net of fees	`ProceedsFromSaleOfEquityUnitsNetOfFees`	$122.03M	USD	Annual
Proceeds from issuance of common stock, net of fees	`ProceedsFromSaleOfEquityUnitsNetOfFees`	$109.45M	USD	2 Qtrs
Proceeds from issuance of common stock, net of fees	`ProceedsFromSaleOfEquityUnitsNetOfFees`	$17.76M	USD	Annual
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$4.45M	USD	Annual
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$8.06M	USD	Annual
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	-	USD	Annual
Proceeds from warrants exercised for common stock	`WarrantsExercisedForStock`	$4.45M	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$735.51K	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Principal payment of notes payable	`RepaymentsOfNotesPayable`	$110.25K	USD	Annual
Principal payment of notes payable	`RepaymentsOfNotesPayable`	$253.96K	USD	2 Qtrs
Principal payment of notes payable	`RepaymentsOfNotesPayable`	$368.69K	USD	Annual
Principal payment of notes payable	`RepaymentsOfNotesPayable`	$285.17K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$126.11M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.47M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.48M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$113.64M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$27.06M	USD	2 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$6.98M	USD	Annual
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-33.78M	USD	Annual
Net increase/(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$33.85M	USD	Annual
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.43M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$9.22M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaidNet`	$4.61K	USD	2 Qtrs
Interest	`InterestPaidNet`	$9.03K	USD	Annual
Interest	`InterestPaidNet`	$2.42K	USD	Annual
Interest	`InterestPaidNet`	$5.93K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	-	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$364.20K	USD	Annual
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	-	USD	2 Qtrs
Notes payable issued in connection with director and officer insurance policies	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$364.20K	USD	Annual
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$43.00	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$68.00	USD	Annual
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$25.00	USD	Annual
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$42.00	USD	Annual
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	-	USD	Annual
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	$62.00	USD	2 Qtrs
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	$62.00	USD	Annual
Cashless exercise of options for common stock	`CashlessExerciseOfOptionsForCommonStock`	$90.00	USD	Annual
Write off for derivative liability due to adoption of ASU 2017-11	`WriteOffForDerivativeLiabilityDueToAdoption`	-	USD	Annual
Write off for derivative liability due to adoption of ASU 2017-11	`WriteOffForDerivativeLiabilityDueToAdoption`	-	USD	2 Qtrs
Write off for derivative liability due to adoption of ASU 2017-11	`WriteOffForDerivativeLiabilityDueToAdoption`	$59.40K	USD	Annual
Conversion of promissory notes and accrued interest to common stock	`ConversionOfPromissoryNotesAndAccruedInterestToCommonStock`	-	USD	Annual
Conversion of promissory notes and accrued interest to common stock	`ConversionOfPromissoryNotesAndAccruedInterestToCommonStock`	$8.03M	USD	Annual
Conversion of promissory notes and accrued interest to common stock	`ConversionOfPromissoryNotesAndAccruedInterestToCommonStock`	-	USD	2 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time
Cumulative effect of Write-off of Derivative Liabilities under ASU 2017-11	`WriteoffOfSeriesDerivativeLiabilityForAdoptionValue`	$59.40K	USD	Annual
Adjusted Balance	`StockholdersEquityAdjustedBalances`	$-5.45M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$20.78M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$2.37M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$1.21M	USD	Annual
Equity offering, net	`EquityOfferingNet`	$19.79M	USD	Annual
Conversion of notes and accrued interest	`StockIssuedDuringPeriodValueConversionOfUnits`	$11.80M	USD	Annual
Equity units issued for cash, net	`StockIssuedDuringPeriodValueOther`	$109.45M	USD	2 Qtrs
Equity units issued for cash, net	`StockIssuedDuringPeriodValueOther`	$17.76M	USD	Annual
Equity units issued for cash, net (in Shares)	`StockIssuedDuringPeriodSharesOther`	19.79M	shares	Annual
Warrants exercised	`StockIssuedDuringPeriodValueWarrantsExercised`	$4.45M	USD	2 Qtrs
Warrants exercised	`StockIssuedDuringPeriodValueWarrantsExercised`	$8.06M	USD	Annual
Options exercised	`OptionsExercised`	$735.51K	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptionsValue`	-	USD	2 Qtrs
Cashless exercise of options	`CashlessExerciseOfOptionsValue`	-	USD	Annual
Shares relinquished by former officer	`SharesRelinquished`	$-394.41K	USD	Annual
Issuance of common stock for cashless exercises of warrants from consultants and Series A Preferred Stock warrant holder	`IssuanceOfCommonStockOnExerciseOfSeriesPreferredStockWarrants`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-59.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.20M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-15.01M	USD	Annual
Balance	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.61M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.